Rare diseases
Investigational molecules
Locations
172 conditions with trials, the busiest first
481 trials across Europe, recruiting first
Study on the Effects of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis
PortugalStudy on Bempedoic Acid with Atorvastatin and Ezetimibe for Patients with Coronary Artery Disease After Heart Attack
GermanyStudy of dapagliflozin effects in patients hospitalized with acute heart failure
CzechiaStudy on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation
BelgiumStudy on Dapagliflozin for Heart Failure Patients After a Heart Attack
FranceStudy on the Effects of Ziltivekimab for Reducing Inflammation in Patients with Coronary Artery Disease
The NetherlandsStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
CzechiaLong-term Study on the Safety and Effectiveness of Odevixibat for Patients with Alagille Syndrome
BelgiumStudy on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction
BulgariaStudy on Glutathione and Sodium Chloride for Preventing Heart Injury in Pneumonia Patients
ItalyStudy on Early Ablation and Use of Amiodarone, Beta-Blockers, or Sotalol for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
PolandStudy on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
DenmarkThe therapies tested most often in Cardiac disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
